Sanofi said Wednesday it will sell monthly supplies of insulin for a fixed price of $ 99 for patients paying with cash in the U.S. as the pharmaceutical giant faces intense pressure from the Trump administration and Congress to lower the cost of its nearly 100-year-old, life-saving medication.
WASHINGTON (Reuters) – Powerful committees in the U.S. Congress held hearings on Tuesday on insulin affordability and high prescription drug prices, an issue both chambers have said is a top priority for the year. FILE PHOTO: U.S. Representative Elijah Cummings (D-MD) speaks with reporters after meeting with President Donald Trump about prescription drug prices at… Read More »
Insulin is a life-saving drug for diabetics. Since 2002, the price has more than tripled and some diabetics can’t afford it. People have died rationing their doses, and some are turning to other countries to buy it at a cheaper price.